All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ3150 | Anti-STK24 (CBXS-4042) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4042 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3151 | Anti-STK24 (CBXS-0785) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0785 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ3152 | Anti-STK24 (CBXS-3087) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3087 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6574 | Anti-STK24 (CBXS-4042) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4042 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6575 | Anti-STK24 (CBXS-0785) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0785 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6576 | Anti-STK24 (CBXS-3087) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-3087 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2585 | Anti-STK24 (CBFYM-0286) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0286 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2586 | Anti-STK24 (CBFYM-3144) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-3144 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5838 | Anti-STK24 (CBFYM-0286) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0286 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5839 | Anti-STK24 (CBFYM-3144) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-3144 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION